159 related articles for article (PubMed ID: 27010024)
1. Clarity on the Isoform-Specific Roles of NADPH Oxidases and NADPH Oxidase-4 in Atherosclerosis.
Fulton DJ; Barman SA
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):579-81. PubMed ID: 27010024
[No Abstract] [Full Text] [Related]
2. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice.
Di Marco E; Gray SP; Chew P; Kennedy K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Clin Sci (Lond); 2016 Aug; 130(15):1363-74. PubMed ID: 27190136
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1.
Ouerd S; Idris-Khodja N; Trindade M; Ferreira NS; Berillo O; Coelho SC; Neves MF; Jandeleit-Dahm KA; Paradis P; Schiffrin EL
Cardiovasc Res; 2021 Mar; 117(4):1144-1153. PubMed ID: 32533834
[TBL] [Abstract][Full Text] [Related]
5. Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques.
Quesada IM; Lucero A; Amaya C; Meijles DN; Cifuentes ME; Pagano PJ; Castro C
Atherosclerosis; 2015 Oct; 242(2):469-75. PubMed ID: 26298737
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidases and vascular remodeling in cardiovascular diseases.
García-Redondo AB; Aguado A; Briones AM; Salaices M
Pharmacol Res; 2016 Dec; 114():110-120. PubMed ID: 27773825
[TBL] [Abstract][Full Text] [Related]
7. The role of NADPH oxidase in vascular disease--hypertension, atherosclerosis & stroke.
Gray SP; Jandeleit-Dahm KA
Curr Pharm Des; 2015; 21(41):5933-44. PubMed ID: 26510435
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Glucose Homeostasis and Diabetes-Related Endothelial Cell Dysfunction.
Brown OI; Bridge KI; Kearney MT
Cells; 2021 Sep; 10(9):. PubMed ID: 34571964
[TBL] [Abstract][Full Text] [Related]
9. Vascular Nox4: a multifarious NADPH oxidase.
Touyz RM; Montezano AC
Circ Res; 2012 Apr; 110(9):1159-61. PubMed ID: 22539753
[No Abstract] [Full Text] [Related]
10. Methods for Detection of NOX-Derived Superoxide Radical Anion and Hydrogen Peroxide in Cells.
Augsburger F; Filippova A; Jaquet V
Methods Mol Biol; 2019; 1982():233-241. PubMed ID: 31172475
[TBL] [Abstract][Full Text] [Related]
11. The NADPH oxidase Nox4 has anti-atherosclerotic functions.
Schürmann C; Rezende F; Kruse C; Yasar Y; Löwe O; Fork C; van de Sluis B; Bremer R; Weissmann N; Shah AM; Jo H; Brandes RP; Schröder K
Eur Heart J; 2015 Dec; 36(48):3447-56. PubMed ID: 26385958
[TBL] [Abstract][Full Text] [Related]
12. NADPH oxidases in cardiovascular health and disease.
Cave AC; Brewer AC; Narayanapanicker A; Ray R; Grieve DJ; Walker S; Shah AM
Antioxid Redox Signal; 2006; 8(5-6):691-728. PubMed ID: 16771662
[TBL] [Abstract][Full Text] [Related]
13. NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous Disease.
Violi F; Carnevale R; Loffredo L; Pignatelli P; Gallin JI
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):218-225. PubMed ID: 27932349
[TBL] [Abstract][Full Text] [Related]
14. NOX4 is a Janus-faced reactive oxygen species generating NADPH oxidase.
Schmidt HH; Wingler K; Kleinschnitz C; Dusting G
Circ Res; 2012 Jun; 111(1):e15-6; author reply e17-8. PubMed ID: 22723224
[No Abstract] [Full Text] [Related]
15. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
[TBL] [Abstract][Full Text] [Related]
16. Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.
Kigawa Y; Miyazaki T; Lei XF; Kim-Kaneyama JR; Miyazaki A
J Atheroscler Thromb; 2017 Jan; 24(1):1-13. PubMed ID: 27476665
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice.
Langbein H; Brunssen C; Hofmann A; Cimalla P; Brux M; Bornstein SR; Deussen A; Koch E; Morawietz H
Eur Heart J; 2016 Jun; 37(22):1753-61. PubMed ID: 26578199
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of Alveolar Macrophage PPARγ, NADPH Oxidases, and TGFβ
Yeligar SM; Ward JM; Harris FL; Brown LAS; Guidot DM; Cribbs SK
AIDS Res Hum Retroviruses; 2017 Oct; 33(10):1018-1026. PubMed ID: 28314381
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin attenuates oxidized low-density lipoprotein induced oxidative stress in human umbilical vein endothelial cells by reducing NADPH oxidase activity.
Chen B; Meng L; Shen T; Gong H; Qi R; Zhao Y; Sun J; Bao L; Zhao G
Biochem Biophys Res Commun; 2017 Sep; 490(4):1326-1333. PubMed ID: 28688762
[TBL] [Abstract][Full Text] [Related]
20. PKCε mediates resistin-induced NADPH oxidase activation and inflammation leading to smooth muscle cell dysfunction and intimal hyperplasia.
Raghuraman G; Zuniga MC; Yuan H; Zhou W
Atherosclerosis; 2016 Oct; 253():29-37. PubMed ID: 27573736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
